PA8575001A1 - Fluorobenzamidas como inhibidores de maob - Google Patents

Fluorobenzamidas como inhibidores de maob

Info

Publication number
PA8575001A1
PA8575001A1 PA20038575001A PA8575001A PA8575001A1 PA 8575001 A1 PA8575001 A1 PA 8575001A1 PA 20038575001 A PA20038575001 A PA 20038575001A PA 8575001 A PA8575001 A PA 8575001A PA 8575001 A1 PA8575001 A1 PA 8575001A1
Authority
PA
Panama
Prior art keywords
hydrogen
alquilo
halogen
fluorobenzamids
nr8r9
Prior art date
Application number
PA20038575001A
Other languages
English (en)
Inventor
Rene Wyler
Andrew William Thomas
Sarmiento Rosa Maria Rodriguez
Synese Jolidon
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of PA8575001A1 publication Critical patent/PA8575001A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/42—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/44—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring
    • C07C235/52—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring having the nitrogen atom of at least one of the carboxamide groups bound to an acyclic carbon atom of a hydrocarbon radical substituted by carboxyl groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/64—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings
    • C07C233/67—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
    • C07C233/68—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
    • C07C233/69—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom of an acyclic saturated carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34—Tobacco-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/64—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings
    • C07C233/66—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by halogen atoms or by nitro or nitroso groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/42—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/44—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring
    • C07C235/48—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring having the nitrogen atom of at least one of the carboxamide groups bound to an acyclic carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/42—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/44—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring
    • C07C235/50—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring having the nitrogen atom of at least one of the carboxamide groups bound to an acyclic carbon atom of a hydrocarbon radical substituted by nitrogen atoms not being part of nitro or nitroso groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C07C255/01—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
    • C07C255/30—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms containing cyano groups and singly-bound nitrogen atoms, not being further bound to other hetero atoms, bound to the same unsaturated acyclic carbon skeleton

Abstract

LA PRESENTE INVENCION SE REFIERE A DERIVADOS DE FLUOROBENZAMIDA DE LA FORMULA GENERAL I: EN DONDE R1 ES HIDROGENO, (C1-C6)-ALQUILO O HIDROXI-(C1-C6)-ALQUILO; R2 ES(C1-C6)-ALQUILO, -CO-NR8R9 -(CH2)N-NR8R9, -(CH2)P-OR8, O -(CH2)N-CN; R3 SE SELECCIONA DE HIDROGENO, HALOGENO, HALOGENO-(C1-C6)- ALQUILO, CIANO, C1-C6-ALCOXILO O HALOGENO-(C1-C6)-ALCOXILO; R4,R5,R6 Y R7 SON HIDROGENO O FLUOR, Y AL MENOS UNO DE R4,R5,R6 Y R7 ES FLUOR; R8 Y R9 INDEPENDIENTEMENTE UNO DEL OTRO SON HIDROGENO O (C1-C6)-ALQUILO; M ES 1,2 0 3; N ES O,1,2 O 3; Y P ES 1 0 2; ASI COMO SUS SALES ACEPTABLES FARMACEUTICAMENTE. LOS COMPUESTOS DE FORMULA GENERAL I SON INHIBIDORES SELECTIVOS MONOAMINO OXIDASA B Y POR LO TANTO ESTOS SON ADECUADOS PARA EL TRATAMIENTO DE LA ENFERMEDAD DE ALZHEIMER O DEMENCIA SENIL.
PA20038575001A 2002-06-12 2003-06-09 Fluorobenzamidas como inhibidores de maob PA8575001A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP02012484 2002-06-12

Publications (1)

Publication Number Publication Date
PA8575001A1 true PA8575001A1 (es) 2003-12-30

Family

ID=29724375

Family Applications (1)

Application Number Title Priority Date Filing Date
PA20038575001A PA8575001A1 (es) 2002-06-12 2003-06-09 Fluorobenzamidas como inhibidores de maob

Country Status (20)

Country Link
US (1) US6951884B2 (es)
EP (1) EP1515926B1 (es)
JP (1) JP4181540B2 (es)
KR (1) KR100641963B1 (es)
CN (1) CN1274669C (es)
AR (1) AR040253A1 (es)
AT (1) ATE427928T1 (es)
AU (1) AU2003236719B2 (es)
BR (1) BR0311719A (es)
CA (1) CA2489247A1 (es)
DE (1) DE60327074D1 (es)
ES (1) ES2322254T3 (es)
MX (1) MXPA04012511A (es)
PA (1) PA8575001A1 (es)
PE (1) PE20040558A1 (es)
PL (1) PL374545A1 (es)
RU (1) RU2314289C2 (es)
TW (1) TW200406201A (es)
UY (1) UY27842A1 (es)
WO (1) WO2003106380A2 (es)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6979750B1 (en) 2003-04-18 2005-12-27 The Regents Of The University Of California Thyronamine derivatives and analogs and methods of use thereof
US7321065B2 (en) 2003-04-18 2008-01-22 The Regents Of The University Of California Thyronamine derivatives and analogs and methods of use thereof
JP3997255B2 (ja) * 2004-02-13 2007-10-24 ワーナー−ランバート カンパニー リミテッド ライアビリティー カンパニー アンドロゲンレセプターモジュレーター
BRPI0513020A (pt) * 2004-07-08 2008-04-22 Warner Lambert Co moduladores de andrÈgenio, seus usos, composição farmacêutica, formulação farmacêutica tópica e artigo de fabricação
UA90708C2 (ru) 2005-02-25 2010-05-25 Ф. Хоффманн-Ля Рош Аг Таблетки с улучшенной дисперсностью лекарственного вещества
WO2006127133A2 (en) 2005-04-01 2006-11-30 Wellstat Therapeutics Corporation Compounds for the treatment of metabolic disorders
TW200724139A (en) * 2005-05-05 2007-07-01 Warner Lambert Co Androgen modulators
WO2007008963A1 (en) * 2005-07-13 2007-01-18 Jenrin Discovery Mao-b inhibitors useful for treating obesity
US20090170886A1 (en) * 2005-08-08 2009-07-02 Pfizer Inc Androgen modulators
US8372885B2 (en) * 2008-09-17 2013-02-12 Novartis Ag Organic compounds and their uses
CN102816082B (zh) * 2010-01-29 2015-03-11 浙江大学 苯甲酰胺类衍生物及制备方法和应用
TWI518062B (zh) * 2011-12-26 2016-01-21 迪愛生股份有限公司 具有２－氟苯基氧基甲烷構造之化合物
KR101613602B1 (ko) 2013-07-25 2016-04-19 디아이씨 가부시끼가이샤 2,6-디플루오로페닐에테르 구조를 갖는 액정성 화합물 및 그 액정 조성물
JP5776864B1 (ja) 2013-08-30 2015-09-09 Dic株式会社 ネマチック液晶組成物
US9573923B2 (en) 2013-10-03 2017-02-21 Dic Corporation Liquid crystal compound having 2, 6-difluorophenylether structure, and liquid crystal composition containing the same
CN106459765B (zh) 2014-07-31 2018-03-09 Dic株式会社 向列型液晶组合物
CN106459767B (zh) 2014-07-31 2019-04-19 Dic株式会社 向列型液晶组合物
CN108912029B (zh) * 2017-08-25 2021-10-01 广东东阳光药业有限公司 含氮杂环酰胺衍生物及其用途
CN110483324A (zh) * 2019-09-10 2019-11-22 深圳振强生物技术有限公司 沙芬酰胺杂质的制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1332151C (en) * 1988-01-28 1994-09-27 Roman Amrein Use of a benzamide to treat cognitive disorder
TW498067B (en) * 1996-07-19 2002-08-11 Hoffmann La Roche 4-hydroxy-piperidine derivatives

Also Published As

Publication number Publication date
WO2003106380A2 (en) 2003-12-24
US6951884B2 (en) 2005-10-04
TW200406201A (en) 2004-05-01
UY27842A1 (es) 2003-12-31
KR100641963B1 (ko) 2006-11-06
JP2005529176A (ja) 2005-09-29
PE20040558A1 (es) 2004-09-09
EP1515926A2 (en) 2005-03-23
CA2489247A1 (en) 2003-12-24
EP1515926B1 (en) 2009-04-08
ES2322254T3 (es) 2009-06-18
PL374545A1 (en) 2005-10-31
US20030236304A1 (en) 2003-12-25
CN1274669C (zh) 2006-09-13
RU2314289C2 (ru) 2008-01-10
WO2003106380A3 (en) 2004-03-11
CN1659135A (zh) 2005-08-24
ATE427928T1 (de) 2009-04-15
DE60327074D1 (de) 2009-05-20
AU2003236719B2 (en) 2008-06-05
KR20050009743A (ko) 2005-01-25
BR0311719A (pt) 2005-03-15
RU2005100755A (ru) 2005-08-10
AU2003236719A1 (en) 2003-12-31
AR040253A1 (es) 2005-03-23
JP4181540B2 (ja) 2008-11-19
MXPA04012511A (es) 2005-02-17

Similar Documents

Publication Publication Date Title
PA8575001A1 (es) Fluorobenzamidas como inhibidores de maob
UY26872A1 (es) Derivados de la 4- fenil piridina
PE20021005A1 (es) Quinazolinas como inhibidores de mmp-13
PE20060777A1 (es) Derivados de indolinona para el tratamiento o la prevencion de enfermedades fibroticas
PA8593101A1 (es) Composiciones para el tratamiento de crecimiento celular anormal
AR039651A1 (es) Derivados de isoquinolina
PE20070078A1 (es) Compuestos heterociclicos macrociclicos como inhibidores de aspartil proteasa
PE20060336A1 (es) Compuestos derivados de 1-amino-ftalazina como moduladores de mch1
PE20021004A1 (es) Derivados de piperidina como inhibidores de la ccr5
UY26276A1 (es) 1,2,4,5- tetrahidro-benzo (d) azepinas ley 17164
AR041297A1 (es) Derivados de 4-pirrolidino- fenil- bencil eter
NO20025641D0 (no) Substituerte 1-aminoalkyl-laktamer og deres anvendelse som muscarin-reseptor-antagonister
PE34297A1 (es) Ligandos especificos del neuropeptido y1
AR040489A1 (es) Compuestos derivados de 3-fenil-propionamido, 3-fenil-acrilamido y 3-fenil-propinamido, su uso para la elaboracion de medicamentos, un proceso para elaborar los compuestos y medicamentos que los contienen
PE20040757A1 (es) Derivados de benzoxazina
PE20030718A1 (es) Lactamas como antagonistas de taquiquininas
NO20050612L (no) Pyrrolidinderivater som oksytocinantagonister
PE20040828A1 (es) Benzoxazinonas como modulares de 5-hidroxitriptamina (5-ht)
UY27232A1 (es) Nuevos compuestos de dihidropirimidina ciano substituidos y su uso para tratar padecimientos
AR037521A1 (es) Derivados de piperazina que tienen actividad antagonista del sst1, un proceso para su preparacion, composicion farmaceutica y el uso de dichos derivados para la manufactura de un medicamento para el tratamiento de la depresion, ansiedad y padecimientos bipolares y una combinacion
AR063775A1 (es) 2- imidazoles sustituidos, un proceso para su obtencion y medicamento preparado en base al compuesto
PE20040765A1 (es) 4-amino piperidinas n,n-disustituidas como inhibidores de la captacion de monoamina
AR041898A1 (es) Derivados de 4(fenil-piperazinil-metil) benzamida y sus usos para el tratamiento del dolor y desordenes gastrointestinales
AR033631A1 (es) 1-oxa-3,9-diaza-espiro[5.5]undecan-2-onas
AR038342A1 (es) Derivados piridin-amido